Pulmonology
From the Journals
E-cigarette use tied to increased COPD, asthma risk
The clinical outcome were consistent with studies assessing in vivo biomarkers of e-cigarette exposure in animal subjects, human participants, and...
Behavioral Consult
To vape or not to vape: Is that really a question?
In addition to its inherent risk, vaping increases the risk of severe COVID-19 disease.
From the Journals
Asthma guidelines update FeNO, intermittent ICS use
Updated asthma management guidelines expand the role for inhaled corticosteroids and fractional exhaled nitric oxide testing.
Commentary
Understanding messenger RNA and other SARS-CoV-2 vaccines
Technological advances make these new and revolutionary vaccines a reality.
From the Journals
Obesity, hypoxia predict severity in children with COVID-19
Race, ethnicity, and socioeconomic status were not significant predictors of serious illness.
Feature
CMS launches hospital-at-home program to free up hospital capacity
The agency will be giving more flexibility to ambulatory surgery centers (ASCs) to provide hospital-level care.
News from the FDA/CDC
FDA expands Xofluza indication to include postexposure flu prophylaxis
Conference Coverage
Telehealth finds acceptance among patients with CF, clinicians
Care model adopted by necessity during the COVID-19 pandemic is likely here to stay.
From the Journals
COVID-19 burdens follow patients after discharge
Postdischarge COVID-19 patients have high rates of long-term sequelae from sepsis and other severe respiratory viral illnesses.
Conference Coverage
Metapneumovirus infections clinically indistinguishable from flu, RSV
Conference Coverage
FDA-approved peanut immunotherapy protocol comes with a cost
Most allergists are not interested in developing home-grown treatments because it comes with legal risks.